medigraphic.com

2008, Number 4

<< Back Next >>

Rev Med Hosp Gen Mex 2008; 71 (4)

Granulomatous rosacea. A case report and review of literature

Sarmiento-Laínez M, Arellano-Mendoza I, Ponce-Olivera RM, Mercadillo-Pérez P

Language: Spanish
References: 19
Page: 204-208
PDF size: 256.83 Kb.


ABSTRACT

Rosacea is a common inflammatory disease affecting the face with flushing, papules, pustules and telangiectasias, which characteristically presents remissions and exacerbations. Its aetiology and pathogenesis are still unknown. Currently it is classified as erythematotelangiectasic, papulopustulous, phymatous, and ocular; granulomatous rosacea is considered a variant. The former presents predominantly in the maxillary and periorificial regions of the face as red or yellowish-brown papules and/or nodules, which sometimes form plaques. Skin biopsy is mandatory for its diagnosis, where a granulomatous infiltrate is found. We present the case of a 46-year-old male with granulomatous rosacea confirmed by biopsy, showing non-caseiting granulomas with periadnexial disposition. The patient was prescribed minocycline 100 mg/día for 12 weeks with complete resolution of the lesions.


REFERENCES

  1. Crawford GH, Pelle MT, James WD. Rosacea: I. etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004; 51: 327-341.

  2. Wilkin J, Dahl M, Detmar M et al. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol 2004; 50: 907-912.

  3. Sanchez JL, Berlingeri-Ramos AC, Dueno D. Granulomatous Rosacea. Am J Dermatopathol 2008; 30: 6-9.

  4. Grunwald MH, Avinoach I, Halevy S. Granulomatous rosacea associated with Demodex folliculorum. Int J Dermatol 1992; 31: 718-719.

  5. Helm KF, Menz J, Gibson LE, Dicken CH. A clinical and histopathologic study of granulomatous rosacea. J Am Acad Dermatol 1991; 25: 1038-1043.

  6. Jansen T. Rosacea. In: Plewig G, Kligman AM (eds). Acne and Rosacea. New York: Spinger; 2000. p. 456-501.

  7. Aylesworth R, Vance JC. Demodex folliculorum and Demodex brevis in cutaneous biopsies. J Am Acad Dermatol 1982; 7: 583-589.

  8. Rebora A, Drago F, Parodi A. May Helicobacter pylori be important for dermatologists? Dermatology 1995; 191: 6–8.

  9. Powell FC. Rosacea: Current concepts of pathogenesis. J Invest Dermatol 1997; 108: 94.

  10. Díaz C, O’Callaghan C, Khan A, Ilchyshyn A. Rosacea: A cutaneous marker of Helicobacter pylori Infection? Results of a pilot study. Acta Derm Venereol 2003; 83: 282-286.

  11. Wilkin J. Why is flushing limited to a mostly facial cutaneous distribution. J Am Acad Dermatol 1988; 19: 309-313.

  12. Wilkin JK. Rosacea. Pathophysiology and treatment. Arch Dermatol 1994; 130: 359-362.

  13. Higgins E, du Vivier A. Alcohol intake and other skin disorders. Clin Dermatol 1999; 17: 437-441.

  14. Van Zuuren E, Gupta A, Gover M, Graber M, Hollis S. Systematic review of rosacea treatments. J Am Acad Dermatol 2007; 56: 107-115.

  15. Pelle M, Crawford G, James W. Rosacea: II. Therapy. J Am Acad Dermatol 2004; 51: 499-512.

  16. Torresani C. Clarithromycin: A new perspective in rosacea treatment. Int J Dermatol 1998; 37: 347-349.

  17. Bamford J, Elliot B, Haller I. Tacrolimus effect on rosacea. J Am Acad Dermatol 2004; 50: 107-108.

  18. Altinyazar C, Koca R, Tekin N, Estürk E. Adapalene vs metronidazole gel for the treatment of rosacea. Int J Dermatol 2005; 44: 252-255.

  19. Webster G, Del Rosso J. Anti-inflammatory activity of tetracyclines. Dermatol Clin 2007; 25: 133-135.




2020     |     www.medigraphic.com